Natalie Eddington, Ph.D.
Dr. Natalie Eddington, a nationally known expert in drug delivery and pharmacokinetics, became Dean of the University of Maryland School of Pharmacy in August 2007. An alumna of the school, Dr. Eddington, was formerly chair of its Department of Pharmaceutical Sciences. After working as assistant director of new drug development at Pfizer Inc., she joined the Maryland School of Pharmacy's faculty in 1991. As School of Pharmacy chair, she guided the launch of the Center for Nanomedicine and Cellular Delivery, which brings together a collection of scientists to find new and better ways of providing pharmaceutical treatment.
Dr. Eddington’s work has been supported by funding from the National Cancer Institute; the National Institute of Mental Health; the National Institute on Drug Abuse; the U.S. Food and Drug Administration; and the pharmaceutical industry. Dr. Eddington was named one of Maryland’s Top 100 Women in 2010 by the Daily Record newspaper, and she was elected in 2010 as Secretary of the Board of Directors of the National Institute of Pharmaceutical Technology and Education. Also in 2010, Dr. Eddington was appointed by the Governor to Maryland's Federal Facilities Advisory Board. Among many honors and awards, she received a “National Women of Color All Star Award” in 2006 from the National Women of Color in Technology Conference.